Concerns About HPV Vaccine Efficacy

They just want shots in arms. It has nothing to do with protection.

When you look at the actual data, the, the HPV vaccine is now given to, uh, children as young as nine years of age, and when we looked at the rate of ovarian function-- dysfunction in children that were 10 that had received the Gardasil 4 vaccine,

they were six times more likely to have an ovarian dysfunction. These were females.

This was back when just girls were getting the vaccine.

But six times more likely at the age of 10 to get an ovarian dysfunction than controls that didn't get the vaccine.

They were twenty-five percent more likely...

Overall, the cohort between, uh, ages 10 and 20, they were, uh, twenty-five percent more likely to be diagnosed with HPV.

And so they showed that they had humapa- human papillomavirus inf- infection, the same infection that doctors like Neil Stone is saying is causing cervical cancer.

And you look at these rates of cervical cancer decline in these countries, th- the cervical cancer rates were already in steep decline because of better screening, because of Pap smears.

So it's very, very difficult to look at this ecological data and these ecological trends, which are moving down very, very gradually, not very, very quickly, and say, "Oh, that is due to the HPV vaccine."

In fact, um, Merck has released information saying that if you get the vaccine and you had a prior HPV infection, then your rates of cervical cancer would actually go up if you get the shot.

So you would think that based on that, they would pre-screen, uh, individuals that were, uh, considering get the H- HPV shot to see if they were already infected. No, they don't.

They don't recommend pre-screening. They just want shots in arms